Biodefense

World Market Report

MCP-1831

EXECUTIVE ENGAGEMENTS

POOL

582
Number of executives repeatedly engaged by snail & email outreach

INTERACTIONS

116
Interactions with Platform & by Email

PARTICIPANTS

23
Unique # Participated

VALIDATIONS

9
Responses Validated*

COMPANIES

22
Responses Validated*
* Login for a full stack data experience

DATE

JAN 2022

TABLES

302

PAGES

363

EDITION

17

PRICE

USD 5450

CODE

MCP-1831


COMPETITIVE METRICS

COMPETITORS (ALPHABETICAL)

STRONG ACTIVE NICHE TRIVIAL

%

VALIDATED RESEARCH *

S A N T
S A N T
S A N T
S A N T
S A N T
S A N T
S A N T
S A N T
S A N T
S A N T

* S = Strong; A = Active; N = Niche; T= Trivial (<1%)
* Login to Participate & View Data Stacks
* Participating executives must be from a competitive company. Executive credentials are validated by a one-time two-factor authentication, in compliance with GDPR guidelines. Verified executives have complimentary access to our proprietary MarketGlassTM platform and relevant data silos including Trend Data; Brand/IP/TM Feeds; and Market Size, Share & Rank Clusters. Qualified influencers are also invited to join our Expert Panels. Privileges include purchase credits, and collaborative bespoke builds.
View All Companies...

PARTICIPATE NOW!
RESEARCH MODULES EXECUTIVES
  

HIGHLIGHTS & REPORT INDEX

What's New for 2022?

» Global competitiveness and key competitor percentage market shares
» Market presence across multiple geographies - Strong/Active/Niche/Trivial
» Online interactive peer-to-peer collaborative bespoke updates
» Access to our digital archives and MarketGlass Research Platform
» Complimentary updates for one year

Amid the COVID-19 crisis, the global market for Biodefense estimated at US$13 Billion in the year 2020, is projected to reach a revised size of US$19.2 Billion by 2027, growing at a CAGR of 5.8% over the analysis period 2020-2027. Anthrax, one of the segments analyzed in the report, is projected to record a 4.6% CAGR and reach US$5.9 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Smallpox segment is readjusted to a revised 5.8% CAGR for the next 7-year period.
The Biodefense market in the U.S. is estimated at US$3.8 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$3.4 Billion by the year 2027 trailing a CAGR of 5.6% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 5.4% and 4.8% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 5% CAGR.
In the global Botulism segment, USA, Canada, Japan, China and Europe will drive the 3.8% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$594.3 Million in the year 2020 will reach a projected size of US$772.8 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$2.2 Billion by the year 2027.

SELECT PLAYERS

Achaogen, Inc.; Alexeter Technologies, LLC; Alnylam Pharmaceuticals, Inc.; Altimmune, Inc.; ANP Technologies, Inc.; Bavarian Nordic A/S; Cleveland BioLabs, Inc.; Elusys Therapeutics, Inc.; Emergent BioSolutions, Inc.; Ichor Medical Systems, Inc.; New Horizons Diagnostic Corporation; PathSensors, Inc.; Research International, Inc.; SIGA Technologies

SEGMENTS

» Product (Anthrax, Smallpox, Botulism, Radiation / Nuclear, Other Products)

GEOGRAPHIES

» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » and Rest of Europe » Asia-Pacific » Rest of World

TABLE OF CONTENTS

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession
Biodefense – Global Key Competitors Percentage Market Share in 2020 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2020 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
World Recent Past, Current & Future Analysis for Biodefense by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2018 through 2027 and % CAGR
World Historic Review for Biodefense by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2017 and % CAGR
World 15-Year Perspective for Biodefense by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2019 & 2027
World Recent Past, Current & Future Analysis for Anthrax by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2018 through 2027 and % CAGR
World Historic Review for Anthrax by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2017 and % CAGR
World 15-Year Perspective for Anthrax by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2019 & 2027
World Recent Past, Current & Future Analysis for Smallpox by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2018 through 2027 and % CAGR
World Historic Review for Smallpox by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2017 and % CAGR
World 15-Year Perspective for Smallpox by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2019 & 2027
World Recent Past, Current & Future Analysis for Botulism by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2018 through 2027 and % CAGR
World Historic Review for Botulism by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2017 and % CAGR
World 15-Year Perspective for Botulism by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2019 & 2027
World Recent Past, Current & Future Analysis for Radiation / Nuclear by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2018 through 2027 and % CAGR
World Historic Review for Radiation / Nuclear by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2017 and % CAGR
World 15-Year Perspective for Radiation / Nuclear by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2019 & 2027
World Recent Past, Current & Future Analysis for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2018 through 2027 and % CAGR
World Historic Review for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2017 and % CAGR
World 15-Year Perspective for Other Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2019 & 2027
World Biodefense Market Analysis of Annual Sales in US$ Million for Years 2012 through 2027
UNITED STATES
Biodefense Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2020 (E)
USA Recent Past, Current & Future Analysis for Biodefense by Product - Anthrax, Smallpox, Botulism, Radiation / Nuclear and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2018 through 2027 and % CAGR
USA Historic Review for Biodefense by Product - Anthrax, Smallpox, Botulism, Radiation / Nuclear and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2017 and % CAGR
USA 15-Year Perspective for Biodefense by Product - Percentage Breakdown of Value Sales for Anthrax, Smallpox, Botulism, Radiation / Nuclear and Other Products for the Years 2012, 2019 & 2027
CANADA
Canada Recent Past, Current & Future Analysis for Biodefense by Product - Anthrax, Smallpox, Botulism, Radiation / Nuclear and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2018 through 2027 and % CAGR
Canada Historic Review for Biodefense by Product - Anthrax, Smallpox, Botulism, Radiation / Nuclear and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2017 and % CAGR
Canada 15-Year Perspective for Biodefense by Product - Percentage Breakdown of Value Sales for Anthrax, Smallpox, Botulism, Radiation / Nuclear and Other Products for the Years 2012, 2019 & 2027
JAPAN
Biodefense Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2020 (E)
Japan Recent Past, Current & Future Analysis for Biodefense by Product - Anthrax, Smallpox, Botulism, Radiation / Nuclear and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2018 through 2027 and % CAGR
Japan Historic Review for Biodefense by Product - Anthrax, Smallpox, Botulism, Radiation / Nuclear and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2017 and % CAGR
Japan 15-Year Perspective for Biodefense by Product - Percentage Breakdown of Value Sales for Anthrax, Smallpox, Botulism, Radiation / Nuclear and Other Products for the Years 2012, 2019 & 2027
CHINA
Biodefense Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2020 (E)
China Recent Past, Current & Future Analysis for Biodefense by Product - Anthrax, Smallpox, Botulism, Radiation / Nuclear and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2018 through 2027 and % CAGR
China Historic Review for Biodefense by Product - Anthrax, Smallpox, Botulism, Radiation / Nuclear and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2017 and % CAGR
China 15-Year Perspective for Biodefense by Product - Percentage Breakdown of Value Sales for Anthrax, Smallpox, Botulism, Radiation / Nuclear and Other Products for the Years 2012, 2019 & 2027
EUROPE
Biodefense Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2020 (E)
Europe Recent Past, Current & Future Analysis for Biodefense by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2018 through 2027 and % CAGR
Europe Historic Review for Biodefense by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2017 and % CAGR
Europe 15-Year Perspective for Biodefense by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2019 & 2027
Europe Recent Past, Current & Future Analysis for Biodefense by Product - Anthrax, Smallpox, Botulism, Radiation / Nuclear and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2018 through 2027 and % CAGR
Europe Historic Review for Biodefense by Product - Anthrax, Smallpox, Botulism, Radiation / Nuclear and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2017 and % CAGR
Europe 15-Year Perspective for Biodefense by Product - Percentage Breakdown of Value Sales for Anthrax, Smallpox, Botulism, Radiation / Nuclear and Other Products for the Years 2012, 2019 & 2027
FRANCE
Biodefense Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2020 (E)
France Recent Past, Current & Future Analysis for Biodefense by Product - Anthrax, Smallpox, Botulism, Radiation / Nuclear and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2018 through 2027 and % CAGR
France Historic Review for Biodefense by Product - Anthrax, Smallpox, Botulism, Radiation / Nuclear and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2017 and % CAGR
France 15-Year Perspective for Biodefense by Product - Percentage Breakdown of Value Sales for Anthrax, Smallpox, Botulism, Radiation / Nuclear and Other Products for the Years 2012, 2019 & 2027
GERMANY
Biodefense Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2020 (E)
Germany Recent Past, Current & Future Analysis for Biodefense by Product - Anthrax, Smallpox, Botulism, Radiation / Nuclear and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2018 through 2027 and % CAGR
Germany Historic Review for Biodefense by Product - Anthrax, Smallpox, Botulism, Radiation / Nuclear and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2017 and % CAGR
Germany 15-Year Perspective for Biodefense by Product - Percentage Breakdown of Value Sales for Anthrax, Smallpox, Botulism, Radiation / Nuclear and Other Products for the Years 2012, 2019 & 2027
ITALY
Italy Recent Past, Current & Future Analysis for Biodefense by Product - Anthrax, Smallpox, Botulism, Radiation / Nuclear and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2018 through 2027 and % CAGR
Italy Historic Review for Biodefense by Product - Anthrax, Smallpox, Botulism, Radiation / Nuclear and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2017 and % CAGR
Italy 15-Year Perspective for Biodefense by Product - Percentage Breakdown of Value Sales for Anthrax, Smallpox, Botulism, Radiation / Nuclear and Other Products for the Years 2012, 2019 & 2027
UNITED KINGDOM
Biodefense Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2020 (E)
UK Recent Past, Current & Future Analysis for Biodefense by Product - Anthrax, Smallpox, Botulism, Radiation / Nuclear and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2018 through 2027 and % CAGR
UK Historic Review for Biodefense by Product - Anthrax, Smallpox, Botulism, Radiation / Nuclear and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2017 and % CAGR
UK 15-Year Perspective for Biodefense by Product - Percentage Breakdown of Value Sales for Anthrax, Smallpox, Botulism, Radiation / Nuclear and Other Products for the Years 2012, 2019 & 2027
REST OF EUROPE
Rest of Europe Recent Past, Current & Future Analysis for Biodefense by Product - Anthrax, Smallpox, Botulism, Radiation / Nuclear and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2018 through 2027 and % CAGR
Rest of Europe Historic Review for Biodefense by Product - Anthrax, Smallpox, Botulism, Radiation / Nuclear and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2017 and % CAGR
Rest of Europe 15-Year Perspective for Biodefense by Product - Percentage Breakdown of Value Sales for Anthrax, Smallpox, Botulism, Radiation / Nuclear and Other Products for the Years 2012, 2019 & 2027
ASIA-PACIFIC
Biodefense Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2020 (E)
Asia-Pacific Recent Past, Current & Future Analysis for Biodefense by Product - Anthrax, Smallpox, Botulism, Radiation / Nuclear and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2018 through 2027 and % CAGR
Asia-Pacific Historic Review for Biodefense by Product - Anthrax, Smallpox, Botulism, Radiation / Nuclear and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2017 and % CAGR
Asia-Pacific 15-Year Perspective for Biodefense by Product - Percentage Breakdown of Value Sales for Anthrax, Smallpox, Botulism, Radiation / Nuclear and Other Products for the Years 2012, 2019 & 2027
REST OF WORLD
Rest of World Recent Past, Current & Future Analysis for Biodefense by Product - Anthrax, Smallpox, Botulism, Radiation / Nuclear and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2018 through 2027 and % CAGR
Rest of World Historic Review for Biodefense by Product - Anthrax, Smallpox, Botulism, Radiation / Nuclear and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2017 and % CAGR
Rest of World 15-Year Perspective for Biodefense by Product - Percentage Breakdown of Value Sales for Anthrax, Smallpox, Botulism, Radiation / Nuclear and Other Products for the Years 2012, 2019 & 2027
Total Companies Profiled: 22

PREVIEW REPORT

YOUR PRIVACY MATTERS!

Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.

What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com